Adverse Drug Effects

Means to Prevent Cardiotoxicity Addressed

Published in Cancer Weekly, June 20th, 2000

Scientists recently concluded that close screening, attention to risk factors, and monitoring for symptoms can prevent cardiotoxicity in patients who have undergone chemotherapy.

V.B. Pai and a colleague from Ohio State University in Columbus, Ohio, discussed the implications of anthracycline cytostatic antibiotics and alkylating agents on the cardiovascular system. Some of the most common chemotherapy treatments, they stated, result in cardiotoxicity. Doxorubicin, danurubicin, and fluorouracil, for instance, may create cardiotoxicity in more than 20% of treated patients. Cardiac complications that may occur at any time after treatment - hours, months, or even years...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-06-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry